Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niloofar Deravi

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Metabolic Brain Disease|January 11, 2022
Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progressionFardin Nabizadeh, Mahsa Pourhamzeh, Saghar Khani, et al.
Heart (British Cardiac Society)|October 8, 2025
Impact of diabetes on outcomes in hypertrophic cardiomyopathy: a GRADE meta-analysisSeyedeh-Tarlan Mirzohreh, Niloofar Deravi, Elnaz Javanshir, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 8, 2021
Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Targeting the STAT3 Signaling PathwayShokoofe Noori, Mostafa Rezaei Tavirani, Niloofar Deravi, et al.
Journal of Pediatric Nursing|November 13, 2020
Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in ChildrenElahe Aleebrahim-Dehkordi, Faezeh Soveyzi, Niloofar Deravi, et al.
BMC Public Health|September 16, 2022
Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose StudyNiloofar Deravi, Seyyed Saeed Moazzeni, Mitra Hasheminia, et al.
Przeglad Epidemiologiczny|February 11, 2021
Chronic non-communicable diseases in the epidemic (COVID-19): Investigation of risk factors, control and careElahe Aleebrahim-Dehkordi, Niloofar Deravi, Ali Reyhanian, et al.
Frontiers in Cardiovascular Medicine|December 26, 2022
Mean versus variability of lipid measurements over 6 years and incident cardiovascular events: More than a decade follow-upSoroush Masrouri, Leila Cheraghi, Niloofar Deravi, et al.
Current Pharmaceutical Biotechnology|August 10, 2021
Antibody Fragment and Targeted Colorectal Cancer Therapy: A Global Systematic ReviewSepideh Ghani, Niloofar Deravi, Marzieh Pirzadeh, et al.
Turkish Journal of Obstetrics and Gynecology|September 4, 2024
The effects of growth hormone supplementation in poor ovarian responders undergoing In vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis of randomized controlled trialsFaezeh Zakerinasab, Qumars Behfar, Reza Parsaee, et al.
Frontiers in Cardiovascular Medicine|August 22, 2022
Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose studyFarzad Hadaegh, Somayeh Hosseinpour-Niazi, Niloofar Deravi, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Metabolic Brain Disease|January 11, 2022
Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progressionFardin Nabizadeh, Mahsa Pourhamzeh, Saghar Khani, et al.
Heart (British Cardiac Society)|October 8, 2025
Impact of diabetes on outcomes in hypertrophic cardiomyopathy: a GRADE meta-analysisSeyedeh-Tarlan Mirzohreh, Niloofar Deravi, Elnaz Javanshir, et al.
Iranian Journal of Pharmaceutical Research : IJPR|March 8, 2021
Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Targeting the STAT3 Signaling PathwayShokoofe Noori, Mostafa Rezaei Tavirani, Niloofar Deravi, et al.
Journal of Pediatric Nursing|November 13, 2020
Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in ChildrenElahe Aleebrahim-Dehkordi, Faezeh Soveyzi, Niloofar Deravi, et al.
BMC Public Health|September 16, 2022
Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose StudyNiloofar Deravi, Seyyed Saeed Moazzeni, Mitra Hasheminia, et al.
Przeglad Epidemiologiczny|February 11, 2021
Chronic non-communicable diseases in the epidemic (COVID-19): Investigation of risk factors, control and careElahe Aleebrahim-Dehkordi, Niloofar Deravi, Ali Reyhanian, et al.
Frontiers in Cardiovascular Medicine|December 26, 2022
Mean versus variability of lipid measurements over 6 years and incident cardiovascular events: More than a decade follow-upSoroush Masrouri, Leila Cheraghi, Niloofar Deravi, et al.
Current Pharmaceutical Biotechnology|August 10, 2021
Antibody Fragment and Targeted Colorectal Cancer Therapy: A Global Systematic ReviewSepideh Ghani, Niloofar Deravi, Marzieh Pirzadeh, et al.
Turkish Journal of Obstetrics and Gynecology|September 4, 2024
The effects of growth hormone supplementation in poor ovarian responders undergoing In vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis of randomized controlled trialsFaezeh Zakerinasab, Qumars Behfar, Reza Parsaee, et al.
Frontiers in Cardiovascular Medicine|August 22, 2022
Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose studyFarzad Hadaegh, Somayeh Hosseinpour-Niazi, Niloofar Deravi, et al.
Pageof 15